Data / Form D filings / NovAb, Inc.
NovAb, Inc.: Form D filings
NovAb, Inc., a biotechnology company in Tucker, GA, filed 9 Form D notices with the SEC between 2016 and 2026. The latest, on April 16, 2026, reports $65,000 sold of a $250,000 offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1860 MONTREAL ROAD, Tucker, GA, 30084
- Phone
- (617) 803-9630
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Georgia
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1685163
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | New notice | $250,000 | $65,000 | $185,000 | 2 | Apr 1, 2026 | sec.gov |
| Jan 26, 2026 | New notice | $50,000 | $50,000 | 2 | Jan 16, 2026 | sec.gov | |
| Aug 12, 2025 | New notice | $210,000 | $210,000 | 2 | Jul 31, 2025 | sec.gov | |
| Feb 11, 2025 | New notice | $250,000 | $250,000 | 3 | Jan 30, 2025 | sec.gov | |
| Jul 12, 2024 | New notice | $125,000 | $125,000 | 2 | Jun 30, 2024 | sec.gov | |
| Aug 11, 2023 | New notice | $250,000 | $250,000 | 3 | Jul 28, 2023 | sec.gov | |
| Mar 9, 2023 | New notice | $300,000 | $300,000 | 3 | Feb 17, 2023 | sec.gov | |
| Mar 16, 2022 | New notice | $300,000 | $300,000 | 5 | Mar 10, 2022 | sec.gov | |
| Sep 30, 2016 | New notice | $600,000 | $0 | $600,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Lovick Edward Cannon | Executive Officer, Director | |
| Gregory Dane | Director | |
| Thomas Chris Cannon | Director |
Other biotechnology companies in Georgia that filed recently
- Opus Medical Therapies, LLC $485,089 · Sep 22, 2026
- Airway Therapeutics, Inc. $43.5 million · Sep 9, 2026
- FEMASYS INC $30 million · Aug 20, 2026
Every Form D from the week of Apr 13, 2026 · All recent filings in Georgia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what NovAb, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.